Anti-mullerian hormone and its role in the regulation of ovarian function. Review of the literature;Le rôle de l'hormone anti-müllérienne dans la régulation du fonctionnement de l'ovaire. Revue de la littérature

Revue Medicale de Bruxelles

Volumn 28, Issue 3, 2007, Pages 165-171

  Tsepelidis, S ^a,b   Demeestere, I ^a,b   Delbaere, A ^a   Gervy, C ^a   Englert, Y ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Anti mullerian hormone; Folliculogenesis; Ovarian reserve

Indexed keywords

FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; MENSTRUATION; NONHUMAN; OVARY FOLLICLE CELL; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; REVIEW;

BIOLOGICAL MARKERS; FEMALE; GLYCOPROTEINS; GONADAL STEROID HORMONES; HUMANS; MULLERIAN DUCTS; NEUROPEPTIDES; OVARIAN DISEASES; OVARIAN FOLLICLE; OVARY; TESTICULAR HORMONES; TRANSFORMING GROWTH FACTOR BETA;

EID: 34447519011     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Cate RL, Mattaliano RJ, Hession C et al. : Isolation of the bovine and human genes for anti-Mullerian hormone and expression of the human gene in animal cells. Cell 1986 ; 45 : 685-98
2. Josso N, Cate RL, Picard JY et al. : Anti-Mullerian hormone : the Jost factor. Recent Prog Horm Res 1993 ; 48 : 1-59
3. Lee MM, Donahoe PK, Hasegawa T et al. : Mullerian inhibiting substance in humans : normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996 ; 81 : 571-6
4. Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL, Skakkebaek NE : Expression of anti-Mullerian hormone during normal and pathological gonadal development : association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999 ; 84 : 3836-44
5. Durlinger AL, Kramer P, Karels B et al. : Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999 ; 140 : 5789-96
6. Gougeon A : Regulation of ovarian follicular development in primates : facts and hypotheses. Endocr Rev 1996 ; 17 : 121-55
7. Mc Gee EA, Hsueh AJ : Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000 ; 21 : 200-14
8. Durlinger AL, Gruijters MJ, Kramer P et al. : Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002 ; 143 : 1076-84
9. Durlinger AL, Gruijters MJ, Kramer P et al. : Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001 ; 142 : 4891-9
10. di Clemente N, Goxe B, Rémy JJ et al. : Inhibitory effect of AMH upon aromatase activity and LH receptors of granulosa cells of rat and porcine immature ovaries. Endocrine 1994 ; 2 : 553-8
11. Weenen C, Laven JS, Von Bergh AR et al. : Anti-Mullerian hormone expression pattern in the human ovary : potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004 ; 10 : 77-83
12. Cook CL, Siow Y, Taylor S, Fallat ME : Serum Mullerian inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000 ; 73 : 859-61
13. La Marca A, Giulini S, Orvieto R, De Leo, Volpe A : Anti-Mullerian hormone concentrations in maternal serum during pregnancy. Human Reproduction 2005 ; 20 : 1569-72
14. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM : Early follicular serum Mulerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002 ; 77 : 468-71
15. van Rooij IAJ, Broeckmans FJM, te Velde ER et al. : Serum anti-Mullerian hormone levels : a novel measure of ovarian reserve. Hum Reprod 2002 ; 17 : 3065-71
16. Fanchin R, Schonauer LM, Righini C, Frydman N, Frydman R, Taieb J : Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 2003 ; 18 : 328-32
17. LaPolt PS, Matt DW, Lu JK : Progesterone implants delay age-related declines in regular estrous cyclicity and the ovarian follicular reserve in Long-Evans rats. Biol Reprod 1998 ; 59 : 197-201
18. Whelan EA, Sandler DP, McConnaughey DR, Weinberg CR : Menstrual and reproductive characteristics and age at natural menopause. Am J Epidemiol 1990 ; 131 : 625-32
19. Cramer DW, Xu H, Harlow BL : Family history as a predictor of early menopause. Fertil Steril 1995 ; 64 : 740-5
20. de Vet A, Laven JS, de Jong FH, Themmen APN, Fauser BC : Anti-Mullerian hormone serum levels : a putative marker for ovarian aging. Fertil Steril 2002 ; 77 : 357-62
21. van Rooij IAJ, Tonkelaar I, Broeckmans FJ et al. : Anti-Mullerian hormone is a promising predictor for the occurence of the menopausal transition. Menopause 2004 ; 11 : 601-6
22. Visser J, de Jong F, Laven J, Themmen A : Anti-Mullerian hormone : a new marker for ovarian function. Reproduction 2006 ; 131 : 1-9
23. Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M : Inhibin B and anti-Mullerian hormone : markers of ovarian response in IVF/ICSI patients ? BJOG 2004 ; 111 : 1248-53
24. Fanchin R, Taieb J, Lozano DH, Ducot B, Frydman R, Bouyer J : High reproductibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in assessment of ovarian follicular status. Hum Reprod 2005 ; 20 : 923-7
25. Pastor CL, Vanderhoof VH, Lim CLC et al. : Pilot study investigating the age-related decline in ovarian function of regularly menstruating normal women. Fertil Steril 2005 ; 84 : 1462-9
26. La Marca A, Malmusi S, Giulini S et al. : Anti-Mullerian hormone plasma levels in spontaneous menstrual cycles and during treatment with FSH to induce ovulation. Hum Reprod 2004 ; 19 : 2738-41
27. Rotterdam Consensus : Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004 ; 19 : 41-7
28. Agarwal SK, Judd HL, Magoffin DA : A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J Clin Endocrinol Metab 1996 ; 81 : 3686-91
29. Fallat ME, Siow Y, Marra M, Cook C, Carrillo A : Mullerian-inhibiting substance in follicular fluid and serum : a comparaison of patients with tubal factor infertility, polycystic ovary syndrome and endometriosis. Fertil Steril 1997 ; 67 : 962-5
30. Cook CL, Siow Y, Brenner AG, Fallat ME : Relationship between serum Mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril 2002 ; 77 : 141-6
31. Pigny P, Merlen E, Robert Y et al. : Elevated serum levels of anti-Mullerian hormone in patients with polycystic ovary syndrome : relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003 ; 88 : 5957-62
32. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC : Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004 ; 89 : 318-23
33. Siow Y, Kives S, Hertweck P, Perlman S, Fallat M : Serum mullerian inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome. Fertil Steril 2005 ; 84 : 938-44
34. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D : Ultrasound examination of polycystic ovary : is it worth counting the follicles ? Hum Reprod 2003 ; 18 : 598-603
35. Eldar-Geva T, Margalioth EJ, Gal M et al. : Serum anti-mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod 2005 ; 20 : 1814-9
36. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M, Bondy CA : Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 1999 ; 61 : 353-7
37. Franks S, Gilling-Smith C, Watson H, Willis D : Insulin action in the normal and polycystic ovary. J Clin Endocrinol Metab 1999 ; 28 : 361-78
38. Fleming R, Harborne L, MacLaughlin DT et al. : Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertil Steril 2005 ; 83 : 130-6
39. La Marca A, Orvieto R, Giulini S, Jasonni VM, Volpe A, De Leo V : Mullerian-inhibiting substance in women with polycystic ovary syndrome : relationship with hormonal and metabolic characteristics. Fertil Steril 2004 ; 82 : 970-2
40. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS : Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005 ; 20 : 1820-6
41. Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen APN, Fauser BC : Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod 2004 ; 19 : 2036-42
42. Webber LJ, Stubbs S, Stark J et al. : Formation and early development of follicles in the polycystic ovary. Lancet 2003 ; 362 : 1017-21
43. Dahlgren E, Johansson S, Lindstedt G et al. : Women with polycystic ovary syndrome wedge resected in 1956 to 1965 : a long term follow-up focusing on natural history and circulating hormones. Fertil Steril 1992 ; 57 : 505-13
44. te Velde ER, Scheffer GJ, Dorland M, Broeckmans FJ, Fauser BC : Developmental and endocrine aspects of normal ovarian ageing. Mol Cell Endocrinol 1998 ; 145 : 67-73
45. Scheffer GJ, Broeckmans FJ, Looman CW et al. : The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 2003 ; 18 : 700-6